From Microscopes to Multimodal AI: A Conversation With Ben Cahoon of Techcyte
From Techcyte: Join us for this Thought Leaders episode as Ben Cahoon, CEO of Techcyte, discusses how the company’s Fusion Platform is redefining digital pathology — bringing together anatomic and clinical pathology into a single, AI-powered workflow.
Hosted by Jonathan Tunstall, CEO and Founder of Pathology News, this Thought Leaders episode features an exclusive interview with: Ben Cahoon, CEO of Techcyte
In this conversation, we explore how Techcyte is building the world’s first unified pathology platform — one that seamlessly integrates digital imaging, AI analysis, and workflow management across human, veterinary, and environmental labs. Ben reflects on his entrepreneurial journey from Intel to leading one of the most innovative pathology software companies in the world, sharing how Techcyte’s early work in clinical pathology shaped its approach to automation, accuracy, and scale.
We discuss the evolution of Fusion AP, its DICOM-based interoperability, and how Techcyte’s open ecosystem enables collaboration with scanner manufacturers and AI developers to drive adoption across the industry. Ben also shares his thoughts on the balance between technology and human expertise, the economic realities of digitisation, and how AI-infused workflow will transform the pathologist’s daily practice.
With a forward-looking perspective on the convergence of data, imaging, and AI, this episode highlights how Techcyte is helping lead the transition from microscopes to multimodal diagnostics — and why the next era of pathology will be powered by platforms built for fusion.
SOURCE: Techcyte
